Trichlormethiazid en es it fr

Trichlormethiazid Brand names, Trichlormethiazid Analogs

Trichlormethiazid Brand Names Mixture

  • No information avaliable

Trichlormethiazid Chemical_Formula


Trichlormethiazid RX_link

No information avaliable

Trichlormethiazid fda sheet

Trichlormethiazid msds (material safety sheet)

Trichlormethiazid MSDS

Trichlormethiazid Synthesis Reference

No information avaliable

Trichlormethiazid Molecular Weight

380.657 g/mol

Trichlormethiazid Melting Point

No information avaliable

Trichlormethiazid H2O Solubility

No information avaliable

Trichlormethiazid State


Trichlormethiazid LogP


Trichlormethiazid Dosage Forms

No information avaliable

Trichlormethiazid Indication

Used in the treatment of oedema (including that associated with heart failure) and hypertension.

Trichlormethiazid Pharmacology

Trichloromethiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Trichloromethiazide has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomer-ulonephritis, and chronic renal failure. Trichloromethiazide is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. Like other thiazides, Trichloromethiazide promotes water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.

Trichlormethiazid Absorption

No information avaliable

Trichlormethiazid side effects and Toxicity

Oral Rat LD50 = 5600 mg/kg, oral Mouse LD50 = 2600 mg/kg

Trichlormethiazid Patient Information

No information avaliable

Trichlormethiazid Organisms Affected

Humans and other mammals